官方服务：
资源简介：
SOX9 overexpression in melanoma
应用场景：
创建时间：
2014-05-09
相关数据集
Additional file 2 of SCUBE3 serves as an independent poor prognostic factor in breast cancer
Additional file 2. The original data.
Figshare2024-02-29 更新80
A Phase 2 Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma
In a post-hoc exploratory analysis of the KING trial to seek molecular markers of outcome, RNAseq was performed on resected tumor specimens at the time of diagnostic surgery before the recurrence from
NIAID Data Ecosystem30
Supplementary Table 2 from Attenuation of microRNA-126 Expression That Drives CD34+38− Stem/Progenitor Cells in Acute Myeloid Leukemia Leads to Tumor Eradication
XLSX file - 14KB, MicroRNAs differentially expressed between LSC and progenitors (at least 4 out of 6 patients): Upper: MicroRNA expression ratios between CD34+CD38-ALDHlow/dim (LSC) and CD34+CD38+ALD
Figshare2014-04-01 更新10
PTEN homozygous deletion is a negative prognostic factor in Tumor Treating Fields-treated glioblastoma, IDH wildtype patients
PTEN homozygous deletion is a negative prognostic factor in Tumor Treating Fields-treated glioblastoma, IDH wildtype patients
ChEBI2025-12-04 更新30
Melanoma, metastatic - Male, 75 - Tissue image [3150630013122441]
This is the histopathological image of STOMACH tissue sample obtained in Medical University Gdańsk and deposited in ZMDL-GUMED. The sample image was taken using: Pannoramic 250 3DHistech slide scanner
DataCite Commons2022-05-24 更新20
